The Association of Community Cancer Centers (ACCC) has launched an interactive, multimedia, online learning portal to provide education on topics most critical to the delivery of cancer care.
Acquire knowledge through comprehensive skill building software, online lectures, videos, readings, supplemental resources, pre and post-assessments, and enrichment opportunities.
Benefit Your Program and Patients
Experience timely and engaging learning on operational, clinical, and administrative topics, with practical case studies, built-in assessments, and on-demand webinars.
Learn at Your Own Pace
Accessible from your tablet, smartphone, or computer any time. Need to stop in the middle of a module? No problem. Pick it up at your convenience.
In Patient Reported Outcomes in Immuno-Oncology , hear experts in the field discuss the basics of patient-reported outcomes (PROs), how PROs can be integrated into IO clinical care, and how PROs can be used in IO clinical trials.
Patient-reported outcomes (PROs) are a critical piece for the cancer care team in assessing the health of a patient and the effect of treatments. PROs are particularly relevant in the rapidly evolving landscape of immuno-oncology (IO) due to variability of immune-related toxicities and potential for late and long-term effects.
ASCO DIRECT™ HIGHLIGHTS condense the most cutting-edge science and education from the world’s premier oncology event, the ASCO Annual Meeting. The abstracts chosen for presentation and discussion reflect state-of-the-art developments and recent advances in oncology that will directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment. Expert faculty place abstract findings into clinical context and discuss how the results may change the current standard of care.
Optimizing Outcomes for Urothelial Carcinoma. With the addition of immunotherapy and other novel targeted agents to the treatment armamentarium for advanced bladder cancer, the care landscape for urothelial carcinoma is evolving. Keep the entire multidisciplinary care team up-to-date with information and resources from the ACCC education program on Optimizing Outcomes for Urothelial Carcinoma in the Community Setting. Two options for participation: a live, on-site learning workshop or as an audio-guided web course.
The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma. This CME, CNE, and CPE-accredited educational program is designed to provide all members of the multidisciplinary care team knowledge and resources to successfully address practical issues and barriers faced in integration of immunotherapies into the treatment of renal cell carcinoma (RCC). The program will be presented in two formats: a live, on-site learning workshop and an audio-guided online course.
Case Studies in IO: A Closer Look at Care Delivery. Second in an education series, this program is organized around four case studies, the discussion will focus on current clinical evidence for optimal selection of immunotherapy and use of combination therapy. Topics covered include monitoring for and managing irAEs, care coordination and communication with non-oncology specialists, and assessment of institution- or practice-specific gaps in IO integration. Shared decision-making, reimbursement, and survivorship will also be discussed.
Financial Advocacy Boot Camp. This program covers the fundamentals of oncology financial advocacy with a targeted focus on navigating today’s complex, fragmented healthcare system.
Immuno-Oncology Fundamentals Elearning Modules. Improve your knowledge of the rapidly developing field of cancer immunotherapies and keep up-to-date with effective practice solutions.
Learn about ACCC's efforts to make the case for hiring comprehensive care team members, as well as the development of a matrix tool to help programs prepare for alternative payment models.
We sit down with journalist Mary Elizabeth Williams, one of the first patients treated with combination immunotherapy, to discuss her experience as an IO patient and how to bridge communication gaps among patients, doctors, and researchers.
We talk to a medical oncologist in a rural Montana community about the realities of rural cancer care, the importance of community oncology, and how he navigates common barriers to quality care.
Guest: Chad Pedersen, MD, Medical Oncologist, Sidney Health Center
Learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency department providers need to know about immune-related adverse events.